Vaccine Adjuvants
We at SPI are actively expanding our influence in the vaccine adjuvants field. Our strategic growth includes executing significant expansion in the vaccine adjuvant technology market and making substantial investments to enhance our capabilities.
Our approach includes strategic partnerships and innovation to incorporate new materials. This has resulted in the addition of saponin-based adjuvants to our portfolio. Also, we are extending our reach with partnerships to offer advanced vaccine systems and explore additional technologies. This, coupled with our 20 years experience in alum vaccine adjuvants, will enable new vaccine development.
Available Products
Adjuvant Systems
SPI Pharma and Inimmune, have created a strategic collaboration to develop and commercialize advanced adjuvant systems for vaccine development. The collaboration leverages Inimmune's world-class expertise in adjuvant formulation and immunotherapeutics and SPI Pharma's extensive manufacturing and global commercial capabilities.
Saponin Based Adjuvants
SPI Pharma offers a range of aluminum hydroxide gel VAC grades for adsorption (pseudo-boehmite form) for use as a vaccine adjuvant. It is used to bind negatively charged antigens.
High Adsorption Alum Adjuvants
The vaccine adjuvant manufacturing process has been optimized to create an adjuvant with a higher protein adsorption capacity, a finer particle size and a narrower pH range. These characteristics make VAC 20 HA a high-performance adjuvant compared to other regular adjuvants.
Alum Vaccine Adjuvants
SPI Pharma offers a range of aluminum hydroxide gel VAC grades for adsorption (pseudo-boehmite form) for use as a vaccine adjuvant. It is used to bind negatively charged antigens.